Delivery Order SPE2DB24D2216-SPE2DB25FGMUM

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,419.63 firm fixed-price delivery order is for CIMZIA 2X200 MG/ML syringe kits, a specialty medication used for various medical conditions. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4,566,736,858 units of CIMZIA 2X200 MG/ML syringe kits, a specialty pharmaceutical product, at a ceiling value of $15,262.94. The contract is a firm fixed-price arrangement with no set-aside designation, indicating...
This is a firm fixed-price delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,065.83, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,820.61 delivery order covers the supply of 4566747735 CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of December 18, 2024 and is a firm fixed price agreement. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of Cimzia 2x200 mg/ml syringe kits to the Defense Logistics Agency (DLA), a defense agency. The $8,438.29 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 11, 2024, with a completion date of December 12, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The $12,838.31 firm-fixed-price delivery order has an ultimate completion date of July 30, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,258.55 delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits, a specialty medication. The award has an ultimate completion date of November 14, 2024 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,558.15 Firm Fixed Price delivery order is for the procurement of Cimzia 2X200 mg/mL syringe kits. The contract has a completion date of December 10, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,679.42 firm fixed-price delivery order contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a period of performance through July 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS with a ceiling value of $39,224.84 and a completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGMUM
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,646.06, is for the delivery of Cimzia 2x200 mg/ml syringe kits, a specialty medication. The contract is a firm fixed-price delivery order with a period of performance through February 4, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/5/25, 9:45 AM